Cargando…

Molecular Characteristics of T Cell-Mediated Tumor Killing in Hepatocellular Carcinoma

BACKGROUND: Although checkpoint blockade is a promising approach for the treatment of hepatocellular carcinoma (HCC), subsets of patients expected to show a response have not been established. As T cell-mediated tumor killing (TTK) is the fundamental principle of immune checkpoint inhibitor therapy,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Wei-feng, Liu, Mou-yuan, Liang, Li, Zhang, Yang, Li, Zong-juan, Han, Keqi, Du, Shi-suo, Chen, Yan-jie, Ma, Li-heng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100886/ https://www.ncbi.nlm.nih.gov/pubmed/35572523 http://dx.doi.org/10.3389/fimmu.2022.868480

Ejemplares similares

New insights into CAR T cell-mediated killing of tumor cells
por: Espie, David, et al.
Publicado: (2022)

Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
por: Chen, Chen, et al.
Publicado: (2023)

Edwardsiella tarda Tunes Tricarboxylic Acid Cycle to Evade Complement-Mediated Killing
por: Cheng, Zhi-xue, et al.
Publicado: (2017)

Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
por: Xiang, Shixin, et al.
Publicado: (2021)

Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma
por: Mo, Zhuomao, et al.
Publicado: (2021)

Characteristics and Clinical Significance of T-Cell Receptor Repertoire in Hepatocellular Carcinoma
por: Wang, Zifei, et al.
Publicado: (2022)

Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma
por: Sun, Ruonan, et al.
Publicado: (2023)

Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment
por: Li, Zuyin, et al.
Publicado: (2022)

How Escherichia coli Circumvent Complement-Mediated Killing
por: Abreu, Afonso G., et al.
Publicado: (2017)

Effects of extracellular adhesion molecules on immune cell mediated solid tumor cell killing
por: Kim, Seong-Eun, et al.
Publicado: (2022)

HBx Mediated Increase of DDX17 Contributes to HBV-Related Hepatocellular Carcinoma Tumorigenesis
por: Dong, Mei-Ling, et al.
Publicado: (2022)

Molecular subtypes and a prognostic model for hepatocellular carcinoma based on immune- and immunogenic cell death-related lncRNAs
por: He, Mingang, et al.
Publicado: (2022)

A novel liver zonation phenotype-associated molecular classification of hepatocellular carcinoma
por: Zhang, Tao, et al.
Publicado: (2023)

Corrigendum: Effects of extracellular adhesion molecules on immune cell mediated solid tumor cell killing
por: Kim, Seong-Eun, et al.
Publicado: (2023)

The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment
por: Xue, Chen, et al.
Publicado: (2022)

H-TEX-mediated signaling between hepatocellular carcinoma cells and macrophages and exosome-targeted therapy for hepatocellular carcinoma
por: Yu, Sihang, et al.
Publicado: (2022)

Single-Cell Transcriptomics Reveals Killing Mechanisms of Antitumor Cytotoxic CD4(+) TCR-T Cells
por: Liang, Yanling, et al.
Publicado: (2022)

Overexpression of SMS in the tumor microenvironment is associated with immunosuppression in hepatocellular carcinoma
por: Xiang, Lin, et al.
Publicado: (2022)

To Kill But Not Be Killed: Controlling the Activity of Mammalian Pore-Forming Proteins
por: Krawczyk, Patrycja A., et al.
Publicado: (2020)

T cell receptor and B cell receptor exhibit unique signatures in tumor and adjacent non-tumor tissues of hepatocellular carcinoma
por: Xie, Shi, et al.
Publicado: (2023)

Epigenetic and Immune-Cell Infiltration Changes in the Tumor Microenvironment in Hepatocellular Carcinoma
por: Wu, Zeng-Hong, et al.
Publicado: (2021)

PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma
por: Song, Fei, et al.
Publicado: (2023)

LRPPRC facilitates tumor progression and immune evasion through upregulation of m(6)A modification of PD-L1 mRNA in hepatocellular carcinoma
por: Wang, Houhong, et al.
Publicado: (2023)

M1 Macrophages Induce PD-L1 Expression in Hepatocellular Carcinoma Cells Through IL-1β Signaling
por: Zong, Zhaoyun, et al.
Publicado: (2019)

Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects
por: Liu, Zhuoyan, et al.
Publicado: (2021)

Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
por: Jiang, Zhiwu, et al.
Publicado: (2017)

Tissue Dimensionality Influences the Functional Response of Cytotoxic T Lymphocyte-Mediated Killing of Targets
por: Gadhamsetty, Saikrishna, et al.
Publicado: (2017)

Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma
por: Xu, Yuyan, et al.
Publicado: (2022)

HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma
por: Shen, Chen, et al.
Publicado: (2023)

Molecular subtypes based on Wnt-signaling gene expression predict prognosis and tumor microenvironment in hepatocellular carcinoma
por: Xu, Weifeng, et al.
Publicado: (2022)

Identification of cuproptosis-related subtypes, cuproptosis-related gene prognostic index in hepatocellular carcinoma
por: Ding, Lei, et al.
Publicado: (2022)

Tyrosine kinase inhibitors as potential sensitizers of adoptive T cell therapy for hepatocellular carcinoma
por: Liang, Linjun, et al.
Publicado: (2023)

Exogenous l-Valine Promotes Phagocytosis to Kill Multidrug-Resistant Bacterial Pathogens
por: Chen, Xin-hai, et al.
Publicado: (2017)

Bibliometric study of immunotherapy for hepatocellular carcinoma
por: Li, Zhiyi, et al.
Publicado: (2023)

Tumor Killing by CD4(+) T Cells Is Mediated via Induction of Inducible Nitric Oxide Synthase-Dependent Macrophage Cytotoxicity
por: Fauskanger, Marte, et al.
Publicado: (2018)

Analysis on heterogeneity of hepatocellular carcinoma immune cells and a molecular risk model by integration of scRNA-seq and bulk RNA-seq
por: Liu, Xiaorui, et al.
Publicado: (2022)

Autoimmunity as a Double Agent in Tumor Killing and Cancer Promotion
por: Toomer, Kevin H., et al.
Publicado: (2014)

Cancer-associated pyroptosis: A new license to kill tumor
por: Kong, Qing, et al.
Publicado: (2023)

Role of exosomes in the development of the immune microenvironment in hepatocellular carcinoma
por: Li, Tanghua, et al.
Publicado: (2023)

Construction of a lipid metabolism-related risk model for hepatocellular carcinoma by single cell and machine learning analysis
por: Mou, Lisha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_isb4vu5g4knb7dac6g9g3ikb9n